Status:
COMPLETED
Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses
Lead Sponsor:
Albert Schweitzer Hospital
Collaborating Sponsors:
Medical Research Unit, Lambarene
Bundesministerium fuer Bildung und Forschung (BMBF)
Conditions:
Malaria
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE4
Brief Summary
The general goal of the project is to assess the infectious status and immunity of mothers and children living in a malaria region. A major part of the study involves administering an effective antima...
Detailed Description
More than 1.5 million deaths of African children under 5 years of age are due to Plasmodium falciparum malaria. There is an urgent need for available and affordable strategies to control malaria morbi...
Eligibility Criteria
Inclusion
- Informed consent
- Permanent residence in the study area
Exclusion
- Allergy/hypersensitivity to sulfonamides or pyrimethamine
- Signs of severe hepatic or renal dysfunction not due to malaria
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
1189 Patients enrolled
Trial Details
Trial ID
NCT00167843
Start Date
December 1 2002
End Date
March 1 2007
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Unit of the Albert Schweitzer Hospital
Lambaréné, Moyen-Ogooué Province, Gabon, B.P. 118